Currently laboratories are able to participate in any, or all of our
- 14 different immmunocytochemistry Modules
- 3 in-situ hybridisation Modules
Modules chosen will depend on your service scope and areas of special interest.
Currently laboratories are able to participate in any, or all of our
Modules chosen will depend on your service scope and areas of special interest.
This module offers FOUR assessment runs per year with the assessment of TWO antigens on each run.
This module offers FOUR assessment runs per year with the assessment of ER at each run
This module offers FOUR assessment runs per year with the assessment of both antigen at each run
This module offers FOUR assessment runs per year with the assessment of HER2 at each run
This module offers FOUR assessment runs per year with the assessment of TWO antigens at each run
This module offers FOUR assessment runs per year with the assessment of TWO antigens at each run
This module offers FOUR assessment runs per year with the assessment of TWO antigens at each run on cytospin preparations or cell block sections, distributed by the scheme and on participants in house controls which should preferably consist of cytoloical preparations
This module offers FOUR assessment runs per year with the assessment of TWO antigens at each run. CD117 is always the Gold and either: DOG-1 or CD34 or Desmin or S100 will be the 2nd antigen
This module offers FOUR assessment runs per year on samples of gastric cancer of varying HER2 membrane protein expression.
This module offers FOUR assessment runs per year on cell lines and tissue samples of varying degrees of HER2 gene status.
This module offers FOUR assessment runs per year on cell lines and tissue samples of varying degrees of ALK expression.
This module offers FOUR assessment runs per year on cell lines and tissue samples of varying degrees of PD-L1 expression.
This module offers FOUR assessment runs per year on cell lines and tissue samples of known ALK and ROS1 gene status.
This module offers FOUR assessment runs per year with the assessment of TWO paired antigens at each run. MLH1 & PMS2 OR MSH2 & MSH6 will be requested alternately.
This module offers FOUR assessment runs per year on cell lines of varying degrees of ROS1 expression.
This module offers FOUR assessment runs per year on breast cancer tissues and cell lines of varying degrees of PD-L1 expression.
This module offers FOUR assessment runs per year on breast cancer tissues and cell lines of varying degrees of Ki-67 expression.
This module offers FOUR assessment runs per year on SCC Head & Neck tumours and cell lines of varying degrees of p16 expression.
This module offers FOUR assessment runs per year on SCC Head & Neck tumours and cell lines of varying degrees of high-risk HPV expression.